0001193125-26-103117
SEC filingWhitehawk Therapeutics Inc filed an 8-K on March 12, 2026, under Item 2.02 announcing results of operations via Press Release in Exhibit 99.1. Item 2.02 and Item 9.01 are not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.